STOCK TITAN
  1. Home
  2. Sec-filings
  3. STXS
  4. [EFFECT] Stereotaxis, Inc. SEC Filing

[EFFECT] Stereotaxis, Inc. SEC Filing

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
EFFECT
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: March 20, 2026 4:00 P.M.
Form: S-3
CIK: 0001289340
Company Name: Stereotaxis, Inc.
File Number: 333-294288

Source: View Original Filing on SEC EDGAR

Stereotaxis Ord

NYSE:STXS

View STXS Stock Overview →

STXS Rankings

#4592 Ranked by Market Cap
N/A Ranked by Dividends

STXS Latest News

Mar 9, 2026
Stereotaxis Reports 2025 Full Year Financial Results
Feb 12, 2026
Stereotaxis to Report Fourth Quarter and Full Year 2025 Financial Results on March 9, 2026
Feb 9, 2026
Klinikum Fürth Establishes Leading Robotic Heart Arrhythmia Program
Jan 6, 2026
Stereotaxis Receives FDA Approval for MAGiC Ablation Catheter
Nov 24, 2025
Stereotaxis to Participate in Piper Sandler 37th Annual Healthcare Conference

STXS Latest SEC Filings

Mar 13, 2026
[S-3] Stereotaxis, Inc. Shelf Registration Statement
Mar 12, 2026
[10-K] Stereotaxis, Inc. Files Annual Report
Mar 9, 2026
[8-K] Stereotaxis, Inc. Reports Material Event
Jan 2, 2026
[Form 4] Stereotaxis, Inc. Insider Trading Activity
Jan 2, 2026
[Form 4] Stereotaxis, Inc. Insider Trading Activity

STXS Stock Data

180.88M
67.24M
Medical Instruments & Supplies
Electromedical & Electrotherapeutic Apparatus
Link
United States
ST.LOUIS